Tumor-infiltrated B cells could secrete anti-B16F10 antibodies, adding an extra beneficial effect to CD8+ and NK cells infiltration and implementing antibody-dependent cell cytotoxicity (ADCC). Here, CD8A is linked to neoplasm.